R. Engelhardt

Procédures opérationnelles standards (POS)

R. Engelhardt, Frank Gärtner, Stephan Mielke, Uwe Frank et autres

Hématologie et hémostase

Jürgen Finke, Hartmut Bertz, Anna-Katharina Kaskel, J. Heinz et autres

Pharmacologie et pharmacothérapie

Dietmar P. Berger, R. Engelhardt, H. Henß, Jurgen S. Scheele et autres

Tumeurs solides

Michael Daskalakis, Karl Henne, H. Henß, Uwe M. Martens et autres

Phase II Study of 4’-lodo-4’-Deoxydoxorubicin in Patients with Advanced, Measurable Non-Small Cell Lung Cancer

Wilfried Eberhardt, N. Niederle, H. Wilke, B. Weidmann et autres

Background: On the basis of preclinical data and phase I trials, a disease-orientated phase II trial was conducted with 4’-iodo-4’-deoxydoxorubicin (I-DOXO) in advanced and measurable non-small cell lung cancer (NSCLC). Patients and Methods: Twenty-three patients with advanced and measurable NSCLC were treated …

de, it (code pays fourni par la source)

Phase-II-Studie von AMSA bei Erwachsenen mit therapierefraktären akuten Leukämien

Heinz‐Herbert Fiebig, H. Henß, R. Engelhardt, David T. Hoelzer et autres

The acridine derivative AMSA, Amsacrine, is a new anticancer drug which was effective in patients with advanced AML and ALL in studies performed in USA. In a multicenter phase II trial we treated 27 patients with acute resistant leukemia with AMSA. All …

de (code pays fourni par la source)

Inhalt, Vol. 6, No. 4, 1983

P.S. Mitrou, Klaus-Peter Hellriegel, D. Hoelzer, Ellen R. Thiel et autres

Impact of Clinical Staging for Neoadjuvant Therapy of Esophageal Cancer

A. Imdahl, J. Sontheimer, Marsha A. Henke, Sebastian Fetscher et autres

Survival of patients with esophageal carcinoma (EC) can be improved by preoperative neoadjuvant chemoradiation followed by esophageal resection. We introduced this treatment modality in 1994. Treatment results of 25 patients presenting with stage Ila/b or III EC (UICC 1987) were analyzed. After …

vn, bd, fr, pk, de (code pays fourni par la source)

Bacteriophage Treatment of Zoonotic Pathogens

James W. Fisher, Adrian Unc, D. McKnight, K. V. M. K. Murthy et autres

Bacteriophage - new technology from an ancient source.

R. Engelhardt, B Rochet

["Silent epidemic". European Congress on Osteoporosis 1998--Berlin].

R. Engelhardt

Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: A mature follow-up report

Sebastian Fetscher, Wolfram Brugger, R. Engelhardt, Lothar Kanz et autres

de (code pays fourni par la source)